Core Insights - Prenetics Global Limited is actively participating in upcoming investor conferences, showcasing its commitment to investor engagement and transparency [2][3]. Group 1: Investor Conferences - The company will attend The Benchmark Company's 14th Annual Discovery One-on-One Conference on December 4, 2025, where CEO Danny Yeung will hold one-on-one meetings with investors [2]. - Prenetics will also participate in Sidoti's Year End Virtual Investor Conference on December 10-11, 2025, with a formal presentation by CEO Danny Yeung on December 10 at 10:00 a.m. Eastern Time, followed by one-on-one meetings with CFO Stephen Lo [3]. Group 2: Company Overview - Prenetics is a leading health sciences company known for its IM8 brand, which has achieved $108 million in Annual Recurring Revenue (ARR) within 12 months of launch, marking the fastest growth in the supplement industry [5]. - The company has established a Bitcoin Treasury, purchasing 1 Bitcoin per day, totaling 501 BTC as of November 24, 2025, indicating its innovative approach at the intersection of health and digital assets [6]. Group 3: IM8 Brand - IM8, co-founded with David Beckham, offers a premium core nutrition product, Daily Ultimate Essentials, which replaces 16 different supplements in a single drink and is NSF Certified for Sport, non-GMO, and vegan [7].

Core Thesis - FitLife Brands (FTLF) is pursuing a roll-up strategy in the supplement industry, which is expected to drive strong growth through the acquisition of smaller companies at low prices, operational improvements, and expanded distribution [1] Company Strategy - The CEO, Dayton Judd, is actively acquiring smaller supplement companies, enhancing their operations, and increasing their market reach [1] Market Focus - The focus is on the supplement industry, which presents significant growth opportunities through consolidation and operational efficiencies [1]

Financial Data and Key Metrics Changes - For Q3 2025, net revenue was $8 million, an increase of 12.4% from $7.1 million in the same quarter last year [11] - Gross margin improved to 70.9% from 67.2% year-over-year, driven by a favorable product mix [11] - Operating expenses rose to $4.4 million from $3.7 million, attributed to costs associated with being a public company and launching the beverage division [11] - Income from operations increased by 21.8% to $1.28 million compared to $1.05 million in Q3 2024 [11] - Net income decreased to $125,300 from $783,600 in the prior year [11] - Earnings per share fell to $0.01 from $0.11, while adjusted EBITDA per share decreased to $0.15 from $0.18 [12] Business Line Data and Key Metrics Changes - Beverage revenue for Q3 was $159,000, indicating early-stage growth in this segment [16] - The supplement business saw a price increase of 11% for Costco, with gross margins around 75% [17] Market Data and Key Metrics Changes - The company secured major distribution agreements, including with EG America and Wakefern Food Group, expanding its retail presence significantly [6][9] - New partnerships with AlaBev and Atlantic Importing Company will enhance distribution in the Southeast and New England regions [6] Company Strategy and Development Direction - The company is focused on expanding its beverage and supplement categories, leveraging new leadership and distribution partnerships [5][10] - A public offering raised $4.4 million to support retail rollouts and inventory build-up, enhancing operational flexibility [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning for growth through 2025 and into 2026, citing strong execution and new retail authorizations [10][24] - The company is actively expanding its direct-to-store distribution network to capitalize on market opportunities [20] Other Important Information - The company has over 3 million cans of drink inventory available, with ongoing production to meet demand [24] - Management highlighted the importance of adding key employees to build out the sales network [24] Q&A Session Summary Question: Contribution from beverages in the quarter - Beverage revenue for Q3 was $159,000 [16] Question: Dynamics of product mix and highest margin revenue source - The supplement business saw an 11% price increase, with gross margins around 75% [17] Question: Expectations for G&A expenses moving forward - G&A expenses may increase due to new executive additions and expansion of the DSD distribution network [19]

Core Insights - ONNIT, a health and wellness brand owned by Unilever, successfully migrated its subscriber base to Ordergroove and Shopify with a 99.6% success rate and no downtime [1][2] Group 1: Technology Integration - The integration of Ordergroove and Shopify provides ONNIT with a scalable tech stack that enhances its subscription model and allows for profitable recurring revenue [2][4] - This new tech foundation enables ONNIT to implement data-driven strategies, such as prepaid models and A/B-tested promotions, which aim to boost customer lifetime value [4][5] - The migration reflects a broader trend among enterprise brands moving away from custom-built systems to integrated platforms that support efficient scaling and profitable growth [6] Group 2: Customer Experience and Growth Strategy - ONNIT has revamped its brand experience with a focus on conversion-oriented user experience, making subscriptions central to its growth strategy [3][4] - The new system allows ONNIT to enhance customer experiences by providing more flexibility and personalized options, thereby fostering long-term relationships and loyalty [5][6] - The partnership with Ordergroove exemplifies how leading brands are prioritizing customer experience as a key driver of growth [6] Group 3: Industry Context - Ordergroove is recognized as a market leader in subscription technology, enabling brands to shift from one-time transactions to profitable recurring relationships [8] - The collaboration between ONNIT, Ordergroove, and Shopify highlights the importance of leveraging advanced technology to meet evolving consumer demands in the subscription economy [6][8]

Financial Data and Key Metrics Changes - Total revenue surged 568% year over year to $23.6 million in Q3 2025, driven by IMA's 76% quarter-to-quarter growth [9] - Adjusted EBITDA loss improved from $6.5 million in Q1 to $2.1 million in Q3, indicating operational leverage and a clear path to profitability [12][17] - Cash increased to approximately $82 million and Bitcoin holdings valued at around $40 million, resulting in total liquidity of about $120 million with zero debt [7][18] Business Line Data and Key Metrics Changes - IMA achieved $100 million annual recurring revenue (ARR) in the last 11 months, with projections to reach $300 million ARR by the end of 2026 [6] - Subscription rate for IMA stands at 80%, with an average order value increasing by 36% quarter over quarter to $150 [10][11] - Gross margin improved to 60% from 52%, reflecting enhanced profitability [10] Market Data and Key Metrics Changes - International markets now account for 56.5% of total revenue, with the U.S. being the top market followed by Canada, the U.K., Australia, and Singapore [10] - IMA has achieved over 420,000 customer purchases across 31 countries, indicating strong global demand [9] Company Strategy and Development Direction - The company aims to create a new category at the intersection of health and wealth, targeting $1 billion in annual revenue by 2030 [6] - A strategic divestment of non-core assets is underway to focus resources on IMA, the highest margin growth engine [14] - The company is leveraging partnerships with high-profile individuals to enhance brand visibility and credibility [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving $180-$200 million in revenue for 2026, driven by international expansion and new product launches [18] - The company is strategically choosing to scale aggressively rather than prioritize short-term profitability, aiming to capture maximum market share [18] Other Important Information - The company has initiated a Bitcoin accumulation strategy, purchasing one Bitcoin daily since August 1, which is part of a sustainable framework to build shareholder value [8] - The recent $44 million funding round attracted notable investors, enhancing the company's financial position [6] Q&A Session Summary Question: Impressive payback period of 3.9 months - Management explained that the payback period has improved from four to five months at launch to 3.9 months now, indicating marketing efficiencies and strong unit economics [19][20] Question: Strong growth in international markets - Management noted that the U.S. market share has decreased from 70% to 46.5%, with significant growth observed in Canada, Europe, the Middle East, and Southeast Asia [21] Question: Need for additional capital for expansion - Management stated that with current liquidity, there is no expectation of needing new capital for expansion, emphasizing operational flexibility from recent fundraising [22][24]

Core Insights - Prenetics Global Limited will release its financial results for Q3 2025 on November 10, 2025, before market open, and will hold its first earnings conference call at 8:30 a.m. Eastern Time on the same day [1][2] Company Overview - Prenetics is a leading health sciences company focused on health and longevity, with its flagship consumer brand IM8 co-founded with David Beckham, which has achieved $100 million in annual recurring revenue within 11 months of launch, marking the fastest growth in the supplements industry [3] - The company has established a Bitcoin Treasury, purchasing 1 Bitcoin per day, totaling 382 BTC as of November 4, 2025, positioning itself at the intersection of health innovation and digital assets [4]

Core Insights - Prenetics Global Limited's IM8 brand achieved approximately $108 million in annualized recurring revenue (ARR) just 11 months post-launch, marking a significant milestone in its growth trajectory [1][4][9] - The company reported a record monthly revenue of $9 million in October, reflecting a 32% increase from September's $6.8 million, driven by strong subscriber growth and improved retention metrics [4][5] - Prenetics recently completed a $44 million equity offering, which is expected to facilitate accelerated global expansion and enhanced marketing initiatives [3][4] Financial Performance - IM8's monthly revenue reached $9 million in October, representing a 32% month-over-month growth from September [5] - The brand has delivered 13 million servings to over 420,000 customers across 31 countries since its launch [5] - IM8 projects a minimum of $10 million in monthly revenue by December 2025, with total revenues expected to be approximately $60 million for FY 2025 and between $180 million and $200 million for FY 2026 [12] Strategic Initiatives - The recent equity raise positions IM8 for aggressive scaling, including exploring partnerships with elite athletes and global wellness thought leaders [4][5] - The launch of the Daily Ultimate Longevity product has contributed to an increase in average order value from approximately $110 to $145, indicating strong consumer demand [5] - Prenetics aims to continue scaling IM8 through 2026 with initiatives focused on global distribution, product innovations, and retention efforts [8] Market Position - IM8 is recognized as the fastest-growing supplement brand globally, achieving $100 million in ARR within just 11 months of launch, surpassing previous records in the supplements industry [9] - The company is also pioneering in the intersection of health innovation and digital assets, having established a Bitcoin Treasury by purchasing 1 Bitcoin per day, totaling 380 BTC as of November 4, 2025 [10]

Core Insights - Prenetics Global Limited has acquired 100 Bitcoin at an average price of $109,594 per Bitcoin, increasing its total Bitcoin holdings to 378 BTC valued at approximately $46 million [1][10] - The acquisition is part of a strategic capital deployment following a successful $44 million equity offering, which was oversubscribed and attracted high-quality strategic investors [2][3] - The company maintains a strong balance sheet with $127 million in total liquidity, consisting of $86 million in cash and $41 million in Bitcoin holdings, while having zero debt [4] Financial Performance - Prenetics' IM8 supplement brand has achieved $100 million in annual recurring revenue within just 11 months of launch, marking the fastest growth in the global supplements industry [5][9] - The company has provided FY2026 revenue guidance for IM8, expecting revenues between $180 million and $200 million [6] Strategic Vision - The CEO's manifesto outlines a vision for a "health-and-wealth" platform, combining growth in the wellness market with strategic Bitcoin accumulation, aiming to create unprecedented shareholder value [7] - Prenetics is recognized as the first consumer health company to establish a Bitcoin Treasury, reinforcing its position at the intersection of health innovation and digital assets [10]

Core Insights - Prenetics Global Limited has published a comprehensive manifesto detailing its strategic vision, combining healthcare growth with Bitcoin treasury management [2][3] - The company's flagship brand, IM8, achieved $100 million in annual recurring revenue within 11 months of launch, marking the fastest growth in the supplement industry [3][6] - Prenetics projects revenue of $180 to $200 million for FY 2026 [3][6] Healthcare Engine (IM8) - IM8 is co-founded by David Beckham and supported by tennis champion Aryna Sabalenka, contributing to its rapid growth [3][6] - The brand's success generates substantial cash flows that facilitate sophisticated Bitcoin treasury management [5] Bitcoin Treasury Engine - As of October 29, 2025, Prenetics holds 277 BTC and employs a disciplined strategy of acquiring 1 BTC daily [4][7] - This Bitcoin treasury is described as a "fortress of value," providing financial resilience and appreciation potential [4] Synergy Between Healthcare and Bitcoin - The integration of IM8's growth with Bitcoin treasury management creates a virtuous cycle, enhancing both healthcare expansion and financial appreciation [5]

Core Viewpoint - Prenetics Global Limited has successfully closed a public offering, raising approximately $44 million to support its global expansion and Bitcoin accumulation strategy [3]. Group 1: Offering Details - The offering included 2,722,642 Class A ordinary shares and associated warrants at a combined price of $16.08 per share [1]. - Class A Common Warrants have an exercise price of $24.12 per share, while Class B Common Warrants are priced at $32.16 per share, representing a 50% and 100% premium to the offering price respectively [2]. - The gross proceeds from the offering were approximately $44 million, which is lower than the previously announced $48 million [3]. Group 2: Use of Proceeds - The proceeds from the offering will be utilized for the global expansion of IM8, Prenetics' flagship consumer brand, and for the strategic accumulation of Bitcoin as part of its health and wealth strategy [3][7]. - Prenetics has established a Bitcoin Treasury, purchasing 1 Bitcoin per day, totaling 275 BTC as of October 27, 2025 [8]. Group 3: Company Background - Prenetics is recognized as a leading health sciences company, co-founded with David Beckham, and has achieved $100 million in annual recurring revenue within 11 months of launching its IM8 brand, marking the fastest growth in the supplements industry [7].